These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7641306

  • 21. Enhancement of clot formation of human plasma by beta-glucans.
    Ohno N, Suzuki T, Saito K, Yadomae T.
    J Pharmacobiodyn; 1990 Sep; 13(9):525-32. PubMed ID: 2084223
    [Abstract] [Full Text] [Related]

  • 22. Isolation and chemical characterization of polysaccharides from Iwatake, Gyrophora esculenta Miyoshi.
    Sone Y, Isoda-Johmura M, Misaki A.
    Biosci Biotechnol Biochem; 1996 Feb; 60(2):213-5. PubMed ID: 9063967
    [Abstract] [Full Text] [Related]

  • 23. Pythium aphanidermatum: culture, cell-wall composition, and isolation and structure of antitumour storage and solubilised cell-wall (1----3),(1----6)-beta-D-glucans.
    Blaschek W, Käsbauer J, Kraus J, Franz G.
    Carbohydr Res; 1992 Jul 02; 231():293-307. PubMed ID: 1394320
    [Abstract] [Full Text] [Related]

  • 24. Activation of the complement system by (1----3)-beta-D-glucans having different degrees of branching and different ultrastructures.
    Suzuki T, Ohno N, Saito K, Yadomae T.
    J Pharmacobiodyn; 1992 Jun 02; 15(6):277-85. PubMed ID: 1432567
    [Abstract] [Full Text] [Related]

  • 25. Structure and antitumor activity of the less-branched derivatives of an alkali-soluble glucan isolated from Omphalia lapidescens. (Studies on fungal polysaccharide. XXXVIII).
    Saito K, Nishijima M, Ohno N, Yadomae T, Miyazaki T.
    Chem Pharm Bull (Tokyo); 1992 Jan 02; 40(1):261-3. PubMed ID: 1576683
    [Abstract] [Full Text] [Related]

  • 26. Expression of interleukin 1 family mRNAs by a highly branched (1-->3)-beta-D-glucan, OL-2.
    Nemoto J, Ohno N, Saito K, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1993 Oct 02; 16(10):1046-50. PubMed ID: 8287038
    [Abstract] [Full Text] [Related]

  • 27. Preparation and antitumor activities of beta-(1-->6) branched (1-->3)-beta-D-glucan derivatives.
    Usui S, Tomono Y, Sakai M, Kiho T, Ukai S.
    Biol Pharm Bull; 1995 Dec 02; 18(12):1630-6. PubMed ID: 8787778
    [Abstract] [Full Text] [Related]

  • 28. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
    Sasaki T, Abiko N, Uchida H, Tanaka M, Nitta K, Yoshioka Y, Nomura H.
    Cancer Treat Rep; 1983 Mar 02; 67(3):275-80. PubMed ID: 6831473
    [Abstract] [Full Text] [Related]

  • 29. Modulation of antitumor activity of grifolan by subsequent administration of (1----3)-beta-D-glucanase in vivo.
    Nono I, Ohno N, Ohsawa M, Oikawa S, Yadomae T.
    J Pharmacobiodyn; 1989 Oct 02; 12(10):581-8. PubMed ID: 2517127
    [Abstract] [Full Text] [Related]

  • 30. The application of various protic acids in the extraction of (1-->3)-beta-D-glucan from Saccharomyces cerevisiae.
    Müller A, Ensley H, Pretus H, McNamee R, Jones E, McLaughlin E, Chandley W, Browder W, Lowman D, Williams D.
    Carbohydr Res; 1997 Apr 21; 299(3):203-8. PubMed ID: 9163899
    [Abstract] [Full Text] [Related]

  • 31. Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa.
    Ohno N, Miura NN, Nakajima M, Yadomae T.
    Biol Pharm Bull; 2000 Jul 21; 23(7):866-72. PubMed ID: 10919368
    [Abstract] [Full Text] [Related]

  • 32. Biological activities of (1-->3)-beta-D-glucans with reducing glucose side chains.
    Kiho T, Matsushita M, Usui S, Ukai S.
    Biosci Biotechnol Biochem; 1998 Mar 21; 62(3):570-2. PubMed ID: 9571788
    [Abstract] [Full Text] [Related]

  • 33. Characterization of sodium hypochlorite degradation of beta-glucan in relation to its metabolism in vivo.
    Miura NN, Ohno N, Adachi Y, Yadomae T.
    Chem Pharm Bull (Tokyo); 1996 Nov 21; 44(11):2137-41. PubMed ID: 8945780
    [Abstract] [Full Text] [Related]

  • 34. Change of biological activities of (1----3)-beta-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment.
    Adachi Y, Ohno N, Ohsawa M, Oikawa S, Yadomae T.
    Chem Pharm Bull (Tokyo); 1990 Feb 21; 38(2):477-81. PubMed ID: 2337961
    [Abstract] [Full Text] [Related]

  • 35. Structural examination of antitumour, water-soluble glucans from Grifora umbellata by use of four types of glucanase.
    Miyazaki T, Oikawa N, Yamada H, Yadomae T.
    Carbohydr Res; 1978 Sep 21; 65(2):235-43. PubMed ID: 308842
    [Abstract] [Full Text] [Related]

  • 36. Oxidative degradation of an antitumor (1-3)-beta-D-glucan, grifolan.
    Nono I, Ohno N, Masuda A, Oikawa S, Yadomae T.
    J Pharmacobiodyn; 1991 Jan 21; 14(1):9-19. PubMed ID: 1907324
    [Abstract] [Full Text] [Related]

  • 37. Purification, antitumor activity, and structural characterization of beta-1,3-glucan from Peziza vesiculosa.
    Mimura H, Ohno N, Suzuki I, Yadomae T.
    Chem Pharm Bull (Tokyo); 1985 Nov 21; 33(11):5096-9. PubMed ID: 3830434
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of high-molecular-weight-(1-->3)-beta-D-glucan-dependent activation of a limulus coagulation factor G by laminaran oligosaccharides and curdlan degradation products.
    Tanaka S, Aketagawa J, Takahashi S, Shibata Y, Tsumuraya Y, Hashimoto Y.
    Carbohydr Res; 1993 May 21; 244(1):115-27. PubMed ID: 8339297
    [Abstract] [Full Text] [Related]

  • 39. Candida albicans cell wall comprises a branched beta-D-(1-->6)-glucan with beta-D-(1-->3)-side chains.
    Iorio E, Torosantucci A, Bromuro C, Chiani P, Ferretti A, Giannini M, Cassone A, Podo F.
    Carbohydr Res; 2008 May 05; 343(6):1050-61. PubMed ID: 18346722
    [Abstract] [Full Text] [Related]

  • 40. Properties of Auricularia auricula-judae beta-D-glucan in dilute solution.
    Zhang L, Yang L.
    Biopolymers; 1995 Dec 05; 36(6):695-700. PubMed ID: 8555417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.